|

Outcomes of a Novel Technique Minimal Scar Mastectomy

RECRUITINGSponsored by KK Women's and Children's Hospital
Actively Recruiting
SponsorKK Women's and Children's Hospital
Started2017-03-01
Est. completion2030-12-31
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06676761

Summary

Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: breast cancer patients who opted for minimal scar mastectomy -

Exclusion Criteria: breast cancer patients who underwent conventional mastectomy

\-

Conditions3

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Cancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.